4.7 Review

Redox-Active Selenium Compounds-From Toxicity and Cell Death to Cancer Treatment

Journal

NUTRIENTS
Volume 7, Issue 5, Pages 3536-3556

Publisher

MDPI
DOI: 10.3390/nu7053536

Keywords

-

Funding

  1. Cancerfonden (The Swedish Cancer Society)
  2. Cancer-och Allergifonden
  3. Stockholm County Council (ALF)
  4. Stichting AF Jochnick Foundation
  5. Radiumhemmets Forskningsfonder

Ask authors/readers for more resources

Selenium is generally known as an antioxidant due to its presence in selenoproteins as selenocysteine, but it is also toxic. The toxic effects of selenium are, however, strictly concentration and chemical species dependent. One class of selenium compounds is a potent inhibitor of cell growth with remarkable tumor specificity. These redox active compounds are pro-oxidative and highly cytotoxic to tumor cells and are promising candidates to be used in chemotherapy against cancer. Herein we elaborate upon the major forms of dietary selenium compounds, their metabolic pathways, and their antioxidant and pro-oxidant potentials with emphasis on cytotoxic mechanisms. Relative cytotoxicity of inorganic selenite and organic selenocystine compounds to different cancer cells are presented as evidence to our perspective. Furthermore, new novel classes of selenium compounds specifically designed to target tumor cells are presented and the potential of selenium in modern oncology is extensively discussed.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available